Amgen Inc. et al. vs. Bristol-Myers Squibb Company
Explore the PTAB proceeding IPR2025-00602 filed by Amgen Inc. et al. on 2025-02-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2025-00602
Filing Date
2025-02-28
Accorded Filing Date
2025-02-28
Institution Decision Date
2025-07-24
Last Modified Date
2025-12-09
Proceeding Type
IPR
Termination Date
2025-07-24
Trial Status
Discretionary Denial
Parties & Counsel
Petitioner
Amgen Inc. et al.
Represented By
McKeown, Scottet alPatent Owner / Respondent
Bristol-Myers Squibb Company
Represented By
Maslowski, Stevenet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Discretionary Denial
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28912 | Robert Sterne | +1 202-772-8555 |
| 29021 | Jorge Goldstein | +1 202-371-2600 |
| 32705 | Elliott Korsen | +1 609-252-4741 |
| 32831 | Tracy-Gene Durkin | +1 202-371-2600 |
| 33876 | Donald Featherstone | +1 202-772-8629 |
| 33997 | Michael Ray | +1 202-772-8569 |
| 34395 | Robert Millonig | +1 202-371-2600 |
| 35239 | Michael Lee | +1 703-628-0233 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 10,174,113 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019019432 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,590,153 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015621539 | US Continuation / Sibling | View Official Patent → |
Bristol-Myers Squibb Company v. Amgen Inc.